|
Coronary disease
|
Country
|
|
US
|
1.24 (0.72–2.13)
|
2.17 (1.12–4.21)*
|
1.25 (0.52–3.01)
|
|
Other
|
0.98 (0.80–1.20)
|
0.89 (0.75–1.23)
|
0.87 (0.62–1.22)
|
|
Sample size
|
|
>10000
|
0.96 (0.80–1.16)
|
0.98 (0.73–1.30)
|
0.89 (0.63–1.25)
|
|
<10000
|
1.42 (0.82–2.45)
|
0.93 (0.49–1.78)
|
1.00 (0.40–2.49)
|
|
Adjusted physical activity
|
|
Yes
|
1.01 (0.80–1.27)
|
0.86 (0.66–1.12)
|
0.85 (0.65–1.11)
|
|
No
|
0.96 (0.63–1.48)
|
1.24 (0.75–2.05)
|
0.91 (0.35–2.38)
|
|
Adjusted serum cholesterol
|
|
Yes
|
1.08 (0.84–1.38)
|
0.96 (0.72–1.28)
|
1.20 (0.80–1.78)
|
|
No
|
0.93 (0.68–1.27)
|
1.00 (0.64–1.57)
|
0.75 (0.52–1.08)
|
|
Adjusted hypertension
|
|
Yes
|
1.09 (0.85–1.40)
|
0.76 (0.49–1.17)
|
1.10 (0.68–1.80)
|
|
No
|
0.92 (0.68–1.26)
|
1.11 (0.83–1.48)
|
0.77 (0.51–1.15)
|
|
Adjusted diabetes
|
|
Yes
|
0.99 (0.78–1.27)
|
0.82 (0.61–1.09)
|
0.86 (0.66–1.12)
|
|
No
|
1.01 (0.72–1.40)
|
1.22 (0.84–1.78)
|
0.83 (0.35–1.97)
|
|
Follow-up duration
|
|
More than 10 years
|
1.01 (0.72–1.40)
|
1.09 (0.83–1.43)
|
0.86 (0.49–1.54)
|
|
Less than 10 years
|
0.99 (0.78–1.27)
|
0.75 (0.48–1.17)
|
0.87 (0.63–1.21)
|
|
Study quality (NOS score)
|
|
8 or 9
|
0.76 (0.50–1.16)
|
0.93 (0.74–1.17)
|
0.70 (0.42–1.17)
|
|
<8
|
1.12 (0.90–1.39)
|
0.98 (0.63–1.54)
|
1.09 (0.76–1.55)
|
|
Total mortality
|
Country
|
|
US
|
1.06 (0.94–1.20)
|
1.14 (0.97–1.33)
|
1.16 (1.02–1.33)*
|
|
Other
|
1.08 (0.94–1.24)
|
1.07 (0.96–1.20)
|
1.01 (0.87–1.18)
|
|
Sample size
|
|
>10000
|
1.06 (0.96–1.16)
|
1.09 (0.99–1.19)
|
1.08 (0.98–1.20)
|
|
<10000
|
1.36 (0.91–2.01)
|
1.25 (0.77–2.03)
|
1.63 (0.87–3.06)
|
|
Adjusted physical activity
|
|
Yes
|
1.10 (0.96–1.26)
|
1.08 (0.96–1.20)
|
1.02 (0.87–1.18)
|
|
No
|
1.05 (0.93–1.18)
|
1.13 (0.97–1.32)
|
1.16 (1.01–1.33)*
|
|
Adjusted serum cholesterol
|
|
Yes
|
1.15 (0.73–1.80)
|
1.21 (0.79–1.86)
|
1.28 (0.61–2.65)
|
|
No
|
1.07 (0.97–1.17)
|
1.09 (0.99–1.19)
|
1.09 (0.98–1.21)
|
|
Adjusted hypertension
|
|
Yes
|
1.08 (0.94–1.24)
|
1.08 (0.87–1.34)
|
1.07 (0.83–1.37)
|
|
No
|
1.06 (0.94–1.20)
|
1.10 (0.99–1.21)
|
1.10 (0.98–1.23)
|
|
Adjusted diabetes
|
|
Yes
|
1.08 (0.93–1.24)
|
1.07 (0.96–1.20)
|
1.01 (0.87–1.18)
|
|
No
|
1.07 (0.95–1.20)
|
1.13 (0.97–1.31)
|
1.16 (1.02–1.33)*
|
|
Follow-up duration
|
|
More than 10 years
|
1.08 (0.98–1.19)
|
1.09 (0.99–1.20)
|
1.10 (0.99–1.22)
|
|
Less than 10 years
|
0.99 (0.72–1.37)
|
1.24 (0.76–2.03)
|
1.04 (0.76–1.43)
|
|
Study quality (NOS score)
|
|
8 or 9
|
1.08 (0.95–1.23)
|
1.08 (0.97–1.21)
|
1.03 (0.88–1.20)
|
|
<8
|
1.06 (0.93–1.21)
|
1.11 (0.95–1.30)
|
1.15 (1.00–1.31)*
|
